Abstract
The study by Jiang et al. [1] to determine the impact of laryngopharyngeal reflux disease (LPRD) on the clinical outcomes in hospitalized patients with novel coronavirus disease 2019 (COVID‐19) is first of its kind study in the literature. While available studies have mostly focused on the effect of cardiovascular comorbidities, the authors' work raises the concurrent gastrointestinal related issues in patients with COVID‐19.
Original language | English |
---|---|
Number of pages | 3 |
Journal | Journal of Medical Virology |
Early online date | 10 Jun 2020 |
DOIs | |
Publication status | E-pub ahead of print - 10 Jun 2020 |